“Eventually, we hope we can either prolong somebody’s life or cure them completely. That’s the ultimate goal.”
Wouter Karthaus is a postdoctoral researcher at Memorial Sloan Kettering. His work concentrates on prostate cancer treatment.
Androgen deprivation therapy, a mainstay for this type of cancer, successfully attacks 90% of cancer cells. Karthaus focuses on the 10% that escape, using mouse models and organoids to parse out which cells are important in cases where cancer cells survive even without the androgen that drives their growth.
Karthaus earned his PhD from the Hubrecht Institute, where his research focused on adult stem biology during homeostasis, disease and regeneration.